0.00Open0.01Pre Close0 Volume5 Open Interest55.00Strike Price0.00Turnover176.28%IV30.77%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0029Delta0.0008Gamma7943.50Leverage Ratio-0.0097Theta0.0000Rho-22.95Eff Leverage0.0006Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet